BioSpace News Archive

Biotech Bay

AMGEN TO PRESENT LONG-TERM OUTCOMES FOR LUMAKRAS® (SOTORASIB) IN KRAS G12C-MUTATED NSCLC AT AACR 2022

Amgen (NASDAQ: AMGN) today announced that new data from across its oncology portfolio and pipeline will be presented at the American Association for Cancer Research (AACR) Annual Meeting from April 8-13 in New Orleans, Louisiana.

March 8, 2022
·
19 min read
Drug Development

Biocytogen Subsidiary, Eucure Biopharma, Announces the First Patient Dosing for a Phase I Multi-regional Clinical Trial of YH002 (Anti-OX40 mAb) in Combination with YH001 (Anti-CTLA-4 mAb) in Australia

Eucure Biopharma, a wholly owned subsidiary of Biocytogen, announced the first patient dosing for a phase I multi-regional clinical trial (MRCT) of YH002 (anti-OX40 monoclonal antibody, mAb) in combination with YH001 (anti-CTLA-4 mAb) (No. YH002004) in Australia.

March 8, 2022
·
3 min read
Stroke Diagnostic and Therapeutic Market to Hit USD 65.45 BN by 2030

The global stroke diagnostic and therapeutic market size is predicted to hit around USD 65.45 billion by 2030 and is expanding growth at a CAGR of 8% over the forecast period 2022 to 2030.

March 8, 2022
·
4 min read
RFID in Healthcare Market Size to Hit US$ 12 Billion by 2027

The global RFID in Healthcare market size is predicted to hit around US$ 12 billion by 2027 and poised to grow at a remarkable CAGR of 21% during the forecast period 2022 to 2027.

March 8, 2022
·
5 min read
Stem Cells Market Size to Worth Around USD 17.79 Bn by 2027

The global stem cells market size is expected to be worth around USD 17.79 billion by 2027 and poised to grow at a CAGR of 8.61% during the forecast period 2022 to 2027.

March 8, 2022
·
5 min read
Pharm Country

Akari Therapeutics, Plc Announces $9.0 Million Registered Direct Offering

Akari Therapeutics, Plc (Nasdaq: AKTX) (“Akari” or the “Company”), today announced that it has entered into definitive agreements with certain institutional investors, accredited investors, and Dr. Ray Prudo, Akari’s Chairman, to receive gross proceeds of approximately $9.0 million.

March 8, 2022
·
5 min read
Biotech Bay

Promaxo Announces Participation at the Oppenheimer 32nd Annual Healthcare Conference

Promaxo, Inc. (“Promaxo” or the “Company”), a medical imaging, robotics, and AI technology company, today announced Amit Vohra, PhD, President and Chief Executive Officer, will participate at the Oppenheimer 32nd Annual Healthcare Conference.

March 8, 2022
·
1 min read
Business

Adaptimmune to Report Q4 and Full Year 2021 Financial Results and Business Updates on Monday, March 14, 2022

Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in cell therapy to treat cancer, will report financial results and provide business updates for the fourth quarter and year ended December 31, 2021, before the US markets open on Monday, March 14, 2022.

March 8, 2022
·
2 min read
Business

Cedars-Sinai Medical Center and AIkido Pharma Inc. Enter Into Master Collaboration Agreement

AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today announced that the Company has entered into a Master Collaboration Agreement (MCA) with Cedars-Sinai Medical Center.

March 8, 2022
·
3 min read
Urinary Incontinence Device Market: Use of Urinary Incontinence Devices Has Experienced a Steep Incline

Rise in incidence of urological disorders, in the last few years, has led to huge development of advanced urinary incontinence devices across the world.

March 8, 2022
·
3 min read